Immunodiagnostics Market is estimated to be US$ 39.69 billion by 2030 with a CAGR of 7.50% during the forecast period - By PMI
May 04, 2022 09:32 ET
|
PMI
Covina, May 04, 2022 (GLOBE NEWSWIRE) -- Immunodiagnostics is a field of in vitro diagnostics that uses antigen antibody responses to diagnose disease. It is used to diagnose infectious infections...
Innit Expands Partnership With Roche Diabetes Care France for Healthy Eating, Enabling Connection to Blood Glucose Meters
April 20, 2022 08:00 ET
|
Innit, Inc
SAN FRANCISCO, April 20, 2022 (GLOBE NEWSWIRE) -- Innit, an innovator in the field of personalized food technology, today announced the extension of its strategic partnership with Roche Diabetes...
Innovaccer Announces Collaboration with Roche to Develop Clinical Decision Support and Workflow Solutions
September 29, 2021 10:33 ET
|
Innovaccer Inc.
SAN FRANCISCO, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Today Innovaccer Inc., the Health Cloud company, announced it has entered into a three-year collaboration with Roche to partner in the development...
AnPac Bio and Roche Pharmaceuticals China Entered into Cooperation to Explore Innovative Healthcare and Medical Solutions
August 05, 2021 07:30 ET
|
Anpac Bio, USA
PHILADELPHIA, Aug. 05, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
GENMARK ALERT: Bragar Eagel & Squire, P.C. Investigates Recently Announced Tender Offer for GNMK and Encourages Investors to Contact the Firm
March 31, 2021 19:50 ET
|
Bragar Eagel & Squire
NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, advises that a tender offer to acquire GenMark Diagnostics, Inc....
GENMARK ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of GNMK and Encourages Investors to Contact the Firm
March 15, 2021 13:57 ET
|
Bragar Eagel & Squire
NEW YORK, March 15, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
Age-related Macular Degeneration Pipeline Analysis of 70+ Key Companies and 70+ Key Therapeutic Products
March 09, 2021 20:20 ET
|
DelveInsight Business Research LLP
Los Angeles, USA , March 09, 2021 (GLOBE NEWSWIRE) -- Age-related Macular Degeneration Pipeline Analysis of 70+ Key Companies and 70+ Key Therapeutic Products DelveInsight anticipates the launch...
Global Non-Invasive Prenatal Testing (NIPT) Market – Analysis and Demand with Forecast Overview to 2029 - by PMI
January 04, 2021 10:05 ET
|
PMI
Covina, CA, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Evolution of prenatal testing, in the form of non-invasive tests that can serve as an intermediate step between screening and invasive tests in order to...
Arch Biopartners Receives Approval from Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide; Begins Screening Patients in Florida
October 07, 2020 07:58 ET
|
Arch Biopartners
TORONTO, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received approval in Turkey from the Ministry...
Immunophotonics Announces Appointment of Jonathan Knowles to Board of Directors
October 05, 2020 10:13 ET
|
ImmunoPhotonics, Inc.
ST. LOUIS, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Immunophotonics, Inc., a biotechnology company focused on the discovery and development of proprietary immune-activating carbohydrate polymers for the...